A 28-year-old woman from Jharkhand presents with fever, headache, and vomiting for 2 days. Thick blood smear shows P. falciparum parasitaemia (4% of RBCs). She is alert, oriented, with no focal neurological signs. Temperature is 38.9°C, BP 110/70 mmHg, RR 22/min, and oxygen saturation 96% on room air. Serum creatinine is 1.2 mg/dL (baseline 0.8), and lactate is 3.2 mmol/L. What is the most appropriate immediate next step?

Explanation

## Clinical Assessment This patient presents with **uncomplicated P. falciparum malaria with early warning signs of severity**: - Parasitaemia 4% (approaching 5% threshold for severe disease) - Elevated lactate 3.2 mmol/L (normal <2 mmol/L) — sign of metabolic dysfunction - Rising creatinine (1.2 from baseline 0.8) — early renal involvement - Tachypnoea (RR 22) — possible metabolic acidosis or early ARDS These findings place the patient at **high risk of progression to severe malaria** within hours. ## WHO Severity Criteria Decision Tree ```mermaid flowchart TD A[P. falciparum parasitaemia confirmed]:::outcome --> B{Severe malaria criteria present?}:::decision B -->|Cerebral, renal, pulmonary, severe anaemia, etc.| C[Definite severe malaria]:::urgent B -->|No, but warning signs| D[Elevated lactate, rising creatinine, tachypnoea]:::urgent D --> E[High risk of progression]:::outcome E --> F[IV artesunate 2.4 mg/kg at 0, 12, 24 hrs, then daily]:::action F --> G[Reassess severity q4-6 hrs]:::action C --> F ``` ## Key Point **Key Point:** WHO 2023 guidelines recommend **IV artesunate for all P. falciparum malaria with parasitaemia ≥4% OR any warning sign** (elevated lactate, rising creatinine, tachypnoea, impaired consciousness, jaundice), even if not yet meeting full severe malaria criteria. Early artesunate initiation prevents progression and reduces mortality. ## Comparison: Uncomplicated vs. Early-Warning Management | Feature | This Patient | True Uncomplicated | |---------|--------------|-------------------| | **Parasitaemia** | 4% (high) | <1% | | **Lactate** | 3.2 mmol/L (elevated) | <2 mmol/L | | **Creatinine trend** | Rising (1.2 from 0.8) | Stable | | **RR** | 22 (tachypnoeic) | 12–16 | | **Recommended therapy** | **IV artesunate** | Oral ACT | ## Clinical Pearl **Clinical Pearl:** Lactate >2 mmol/L in malaria is a **harbinger of severe disease** and indicates tissue hypoperfusion or metabolic acidosis. Even without overt cerebral or renal failure, elevated lactate mandates parenteral artesunate. This patient's rising creatinine (delta +0.4 mg/dL over 2 days) signals **early acute kidney injury** — another reason to escalate to IV therapy. ## High-Yield **High-Yield:** Do NOT wait for parasitaemia to reach 5% or for full severe malaria criteria to manifest. WHO 2023 emphasizes **early recognition of warning signs** (lactate, creatinine, RR, altered consciousness, jaundice) as triggers for IV artesunate. Early escalation prevents multi-organ failure and reduces mortality by ~35%. ## Warning **Warning:** Oral ACTs are inappropriate when warning signs are present. Lumbar puncture is contraindicated in suspected cerebral malaria without prior neuroimaging and should never delay antimalarial therapy. Quinine is second-line only and inferior to artesunate.